Literature DB >> 32909738

Nuclear Receptor Chemical Reporter Enables Domain-Specific Analysis of Ligands in Mammalian Cells.

Taku Tsukidate1, Qiang Li1, Howard C Hang1,2.   

Abstract

The characterization of specific metabolite-protein interactions is important in chemical biology and drug discovery. For example, nuclear receptors (NRs) are a family of ligand-activated transcription factors that regulate diverse physiological processes in animals and are key targets for therapeutic development. However, the identification and characterization of physiological ligands for many NRs remains challenging, because of limitations in domain-specific analysis of ligand binding in cells. To address these limitations, we developed a domain-specific covalent chemical reporter for peroxisome proliferator-activated receptors (PPARs) and demonstrated its utility to screen and characterize the potency of candidate NR ligands in live cells. These studies demonstrate targeted and domain-specific chemical reporters provide excellent tools to evaluate endogenous and exogenous (diet, microbiota, therapeutics) ligands of PPARs in mammalian cells, as well as additional protein targets for further investigation.

Entities:  

Year:  2020        PMID: 32909738      PMCID: PMC8147873          DOI: 10.1021/acschembio.0c00432

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  49 in total

1.  Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.

Authors:  Lulu Sun; Cen Xie; Guang Wang; Yue Wu; Qing Wu; Xuemei Wang; Jia Liu; Yangyang Deng; Jialin Xia; Bo Chen; Songyang Zhang; Chuyu Yun; Guan Lian; Xiujuan Zhang; Heng Zhang; William H Bisson; Jingmin Shi; Xiaoxia Gao; Pupu Ge; Cuihua Liu; Kristopher W Krausz; Robert G Nichols; Jingwei Cai; Bipin Rimal; Andrew D Patterson; Xian Wang; Frank J Gonzalez; Changtao Jiang
Journal:  Nat Med       Date:  2018-11-05       Impact factor: 53.440

Review 2.  Small-Molecule Target Engagement in Cells.

Authors:  Marc Schürmann; Petra Janning; Slava Ziegler; Herbert Waldmann
Journal:  Cell Chem Biol       Date:  2016-03-31       Impact factor: 8.116

3.  N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

Authors:  B R Henke; S G Blanchard; M F Brackeen; K K Brown; J E Cobb; J L Collins; W W Harrington; M A Hashim; E A Hull-Ryde; I Kaldor; S A Kliewer; D H Lake; L M Leesnitzer; J M Lehmann; J M Lenhard; L A Orband-Miller; J F Miller; R A Mook; S A Noble; W Oliver; D J Parks; K D Plunket; J R Szewczyk; T M Willson
Journal:  J Med Chem       Date:  1998-12-03       Impact factor: 7.446

4.  Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

Authors:  Manu V Chakravarthy; Irfan J Lodhi; Li Yin; Raghu R V Malapaka; H Eric Xu; John Turk; Clay F Semenkovich
Journal:  Cell       Date:  2009-07-30       Impact factor: 41.582

5.  A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.

Authors:  Sun-Sil Choi; Eun Sun Kim; Minseob Koh; Soo-Jin Lee; Donghyun Lim; Yong Ryoul Yang; Hyun-Jun Jang; Kyung-Ah Seo; Sang-Hyun Min; In Hee Lee; Seung Bum Park; Pann-Ghill Suh; Jang Hyun Choi
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

6.  Tunable Heteroaromatic Sulfones Enhance in-Cell Cysteine Profiling.

Authors:  Hashim F Motiwala; Yu-Hsuan Kuo; Brittany L Stinger; Bruce A Palfey; Brent R Martin
Journal:  J Am Chem Soc       Date:  2020-01-13       Impact factor: 15.419

7.  Cysteine-reactive probes and their use in chemical proteomics.

Authors:  Dominic G Hoch; Daniel Abegg; Alexander Adibekian
Journal:  Chem Commun (Camb)       Date:  2018-05-01       Impact factor: 6.222

8.  Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.

Authors:  Jang Hyun Choi; Alexander S Banks; Theodore M Kamenecka; Scott A Busby; Michael J Chalmers; Naresh Kumar; Dana S Kuruvilla; Youseung Shin; Yuanjun He; John B Bruning; David P Marciano; Michael D Cameron; Dina Laznik; Michael J Jurczak; Stephan C Schürer; Dušica Vidović; Gerald I Shulman; Bruce M Spiegelman; Patrick R Griffin
Journal:  Nature       Date:  2011-09-04       Impact factor: 49.962

9.  Proteome-wide covalent ligand discovery in native biological systems.

Authors:  Keriann M Backus; Bruno E Correia; Kenneth M Lum; Stefano Forli; Benjamin D Horning; Gonzalo E González-Páez; Sandip Chatterjee; Bryan R Lanning; John R Teijaro; Arthur J Olson; Dennis W Wolan; Benjamin F Cravatt
Journal:  Nature       Date:  2016-06-15       Impact factor: 49.962

10.  Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands.

Authors:  Hwan Bae; Jun Young Jang; Sun-Sil Choi; Jae-Jin Lee; Heejun Kim; Ala Jo; Kong-Joo Lee; Jang Hyun Choi; Se Won Suh; Seung Bum Park
Journal:  Chem Sci       Date:  2016-05-13       Impact factor: 9.825

View more
  1 in total

1.  4-Iodopyrimidine Labeling Reveals Nuclear Translocation and Nuclease Activity for Both MIF and MIF2.

Authors:  Zhangping Xiao; Deng Chen; Fabian Mulder; Shanshan Song; Petra E van der Wouden; Robbert H Cool; Barbro N Melgert; Gerrit J Poelarends; Frank J Dekker
Journal:  Chemistry       Date:  2021-11-22       Impact factor: 5.020

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.